Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Endocrinology and metabolic disorders 13

Endocrinology and Metabolic Disorders

weight-loss-obesity-market

Snippets - A Small piece of News or Article

An Insight Into the Weight Loss and Obesity Market

Obesity is one of the significant global health challenges, having a severe socio-economic impact. It is basically an imbalance in calories consumed versus calories expended. Over the past two to three decades, it has grown to be a global epidemic and impacting people across age and geographic regions, which has a direct influence on morbidity and mortality. Several factors such as genetics, a sedentary lifestyle, high consumption of fat and sugars (energy-dense foods), daily routine, taking certain medications, endocrine problems, and physical inactivity contributed immensely to obesity. Similarly, environmental or societal changes, behaviour, and culture also ...

Explore More...

astellas

Commercial

Digital Pills

Digital Pill: A new frontier in digital healthcare all set to take-off

astellas

Commercial

Notizia

Celiac vaccine trial; New discovery in Nicotine; Nabriva lines up FDA filing; Rare Disease drug development accelerating

BioGen

Business Cocktail

transthyretin amyloidosis

Notizia

Novo petitions FDA;J&J invests; Xarelto’s trial; Roche’s Tecentriq

Therapeutics and Celgene to develop therapies; Takeda’s expansion; J&J hopes to limit; Tech Prize for genome sequencing; Endocyte’s late-stage prostate cancer deal

Business CockTail

Personalized Medicine

Sanofi invests; ICER pitches; $6M in NIH; Pfizer, Roche cancer drug pricing

Invokana matches; Xultophy beats; Lilly and BI follow; Tresiba matches

Personalized Medicine

Merck’s Remicade; Sanofi, Regeneron set Kevzara; Novartis to sever; Teva puts women’s health

Humira’s patent; Teva laying off; GSK aims; Thermo acquires Patheon; J& J’s Invokana

Cancer, diabetes and eczema on list; AbbVie’s Humira; Teva weighs $2B; Fresenius in buyout talks

Acromegaly and Gigantism: It’s all about excessive Growth Hormone…

A Probiotic drink from the gut microbiome of an elite athlete

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly